The world’s most profitable hedge fund has started betting against shares in GSK (GSK), the first significant short on the FTSE 100 drugmaker’s stock for more than a decade, The Times’ Ben Martin ...
Welcome to the FT's hub of puzzles, games and quizzes. Print out the crosswords to complete them or Subscribers can now solve the FT’s Daily Cryptic, Polymath and FT Weekend crosswords on the iOS and ...
Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...
(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...
Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...
Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...
Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.
Robert F. Kennedy Jr, a vaccine critic who has pledged to tackle chronic disease, was confirmed by the U.S. Senate as Health ...
AstraZeneca Plc reported better-than-expected profit and revenue in the fourth quarter and forecast further gains, helped by ...
CHARLESTON, S.C. -- The Citadel football program announced the program’s 2025 schedule Thursday afternoon, compiling a formidable four-game non-conference lineup along with the usual eight-contest ...
The company recognized $19.3 million in non-recurring revenue from a prior agreement with GSK but faced an overall 8% decline in consumer services revenue, totaling $39.6 million, due to decreased ...
Fans of spy thriller shows are eagerly awaiting news on Citadel season 2, but after a busy flurry of activity at the end of 2024 for the Prime Video action franchise, things have gotten a bit quiet in ...